The future of NMDR research lies in advancing our understanding of the biological mechanisms that drive these responses. This includes the development of new biotechnological tools and computational models to predict NMDRs more accurately. Collaborative efforts among toxicologists, endocrinologists, and regulatory agencies are crucial to address the complexities of NMDRs. As research progresses, it could lead to more comprehensive risk assessment strategies that better protect human health and the environment.
In conclusion, non-monotonic dose responses represent a paradigm shift in toxicology, challenging traditional dose-response assumptions and necessitating a reevaluation of chemical risk assessment practices. Understanding and addressing NMDRs is essential for ensuring that regulatory decisions are based on the most accurate and comprehensive scientific data available.
